英国科学家正在研发针对此次刚果埃博拉疫情的疫苗，预计数月内即可进入临床试验阶段。

此次爆发的埃博拉病毒属于罕见的邦迪布焦型（Bundibugyo），致死率约为三分之一，目前尚无获批的针对性疫苗。世界卫生组织已将此次疫情的风险评估上调，称其"正在迅速扩散"。

在刚果民主共和国，愤怒的民众因无法安葬疑似埃博拉遇难者遗体，焚烧了医疗帐篷，反映出社区对防疫措施的强烈抵触。

英国研发团队的疫苗如能如期推进，将成为应对邦迪布焦型埃博拉的重要工具。此前针对扎伊尔型埃博拉的疫苗已在疫情中证明了其有效性，但邦迪布焦型的疫苗研发仍处于早期阶段。

English

UK scientists are developing a vaccine for the current Ebola outbreak in the Democratic Republic of Congo, with clinical trials expected to begin within months.

The outbreak involves the rare Bundibugyo species of Ebola, which kills approximately one-third of those infected and has no approved vaccine. The WHO has upgraded its risk assessment, saying the outbreak is “spreading rapidly.”

In eastern DR Congo, angry crowds burned medical tents after being prevented from burying the body of a suspected Ebola victim, highlighting community resistance to containment measures.

If successful, the UK-developed vaccine would become a critical tool against the Bundibugyo strain. Vaccines for the more common Zaire strain have proven effective in past outbreaks, but Bundibugyo vaccine development remains in early stages.

The FDA has stopped publishing safety studies on COVID and shingles vaccines, raising transparency concerns.

FDA已停止发布关于新冠疫苗和带状疱疹疫苗的安全性研究，引发了对疫苗安全监测透明度的担忧。此举在公共卫生领域引发争议，批评者认为公众有权了解疫苗安全数据。